Harsha Engineers International, incorporated in the year 2010, is a Small Cap company (having a market cap of Rs 3068.64 Crore) operating i...

360 ONE WAM, incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 17103.73 Crore) operating in in wealth manageme...

As per the World Health Organisation (WHO), the total number of incident TB patients (new and relapse) in 2021 in India was 19,33,381, a 19...

Promoters held 60.89 per cent stake in the company as of 30-Jun-2022, while FIIs owned 5.18 per cent, DIIs 10.01 per cent.

Promoters held 60.89 per cent stake in the company as of 30-Jun-2022, while FIIs owned 5.18 per cent, DIIs 10.01 per cent.

Zydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42548.00 Crore) operating in Phar...

Gujarat Gas, incorporated in the year 2012, is a Mid Cap company (having a market cap of Rs 35214.60 Crore) operating in Gas & Petroleum se...

The brokerage has raised earnings estimates by 2-10% to reflect the strong earnings beat in the third quarter.

The analyst suggested a stoploss at Rs 250.

Sell Cadila Healthcare Ltd. at a price target of Rs 345.0 and a stoploss at Rs 362 from entry point.

Sell Cadila Healthcare Ltd. at a price target of Rs 373.0 and a stop loss at Rs 402 from entry point.

Buy Cadila Healthcare Ltd. at a price target of Rs 435.0 and a stop loss at Rs 419 from entry point.

Sell Cadila Healthcare at a price target of Rs 445 and a stop loss at Rs 470 from entry point.

Buy Cadila Healthcare Ltd. at a price target of Rs 540.0 and a stop loss at Rs 453.0 from entry point

Buy Cadila Healthcare Ltd. at a price target of Rs 480.0 and a stop loss at Rs 460.0 from entry point

GoM headed by Sharad Pawar tasked with the mandate to finalise the country's drug pricing policy heard the views of industry bodies stakeho...

The tests will initially be only for cancer patients and Mr Saxena’s company, Acton Biotech, plans to cover other diseases later.